UBS Group’s Artivion AORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-1,500
Closed -$17K 8764
2014
Q4
$17K Buy
+1,500
New +$15.5K ﹤0.01% 7859

Other funds holding AORT

UBS Group's AORT Position: Q2 2026 in Review

UBS Group increased its Artivion (AORT) stake by 77% in Q2 2026, buying an estimated $5.52M and bringing the position to 454,401 shares worth $10.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3422.

UBS Group first reported a position in AORT in Q4 2014 and has held it in 47 quarters since. The position peaked at $12.8M in Q4 2025. 206 funds tracked by Wall St. Rank hold AORT as of Q2 2026.

  • UBS Group held 454,401 shares of Artivion worth $10.2M as of Q2 2026.
  • UBS Group bought 197,479 Artivion shares in Q2 2026, an estimated $5.52M.
  • Artivion made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #3422 holding.
  • UBS Group first reported a position in Artivion in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Artivion position peaked at $12.8M in Q4 2025.
  • 206 funds tracked by Wall St. Rank held Artivion as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.